(Q37206612)

18 August 2017

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis (English)

1 reference

18 August 2017

8

Georg Schett

1 reference

18 August 2017

Xiao-Xiang Chen

1

1 reference

18 August 2017

Wolfgang Baum

2

1 reference

18 August 2017

Denise Dwyer

3

1 reference

18 August 2017

Michael Stock

4

1 reference

18 August 2017

Kay Schwabe

5

1 reference

18 August 2017

Hua-Zhu Ke

6

1 reference

18 August 2017

Marina Stolina

7

1 reference

18 August 2017

Aline Bozec

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

10 May 2013

1 reference

Annals of the Rheumatic Diseases

18 August 2017

1 reference

18 August 2017

72

1 reference

18 August 2017

10

1 reference

18 August 2017

1732-1736

1 reference

The pathogenesis of rheumatoid arthritis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Targeting sclerostin as potential treatment of osteoporosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

From bone biology to clinical outcome: state of the art and future perspectives

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Disease activity and severity in early inflammatory arthritis predict hand cortical bone loss

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Osteoporosis and arthritis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786639

Dickkopf-1 is a master regulator of joint remodeling

3 September 2018

1 reference

12 December 2020

Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis

1 reference

12 December 2020

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

1 reference

12 December 2020

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up

1 reference

12 December 2020

10.1136/ANNRHEUMDIS-2013-203345

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference